Organoid Platform in Preclinical Investigation of Personalized Immunotherapy Efficacy in Appendiceal Cancer: Feasibility Study https://t.co/jFY3Nw0zFM
Organoid Platform in Preclinical Investigation of Personalized Immunotherapy Efficacy in Appendiceal Cancer: Feasibility Study https://t.co/620npHuZAj
RT @KVotanopoulos: Our new pub in CCR is now early released online. Immunotherapy effect on appendiceal cancer treated with CRS/HIPEC. C…
RT @StevenDForsythe: I am excited to announce our work has been published @CCR_AACR. This article demonstrates the application of organoids…
Today's read 162 #Organoids @CCR_AACR #Organoid Platform in Preclinical Investigation of Personalized #Immunotherapy Efficacy in #Appendiceal Cancer: Feasibility Study https://t.co/rJOpNxRa5h
RT @StevenDForsythe: I am excited to announce our work has been published @CCR_AACR. This article demonstrates the application of organoids…
RT @StevenDForsythe: I am excited to announce our work has been published @CCR_AACR. This article demonstrates the application of organoids…
RT @StevenDForsythe: I am excited to announce our work has been published @CCR_AACR. This article demonstrates the application of organoids…
RT @StevenDForsythe: I am excited to announce our work has been published @CCR_AACR. This article demonstrates the application of organoids…
Wake Forest Baptist Health (@wfubmc) scientists conducted a feasibility study to explore the application of #immunotherapy in treating #appendiceal in a personalized organoid model. https://t.co/SgnUd4AiHN https://t.co/ir1K4VAcfK
I am excited to announce our work has been published @CCR_AACR. This article demonstrates the application of organoids as a platform for immunotherapy testing in appendiceal cancer, a rare but devastating disease. Thank you @KVotanopoulos @RAEraliMD https
RT @KVotanopoulos: Our new pub in CCR is now early released online. Immunotherapy effect on appendiceal cancer treated with CRS/HIPEC. C…
RT @KVotanopoulos: Our new pub in CCR is now early released online. Immunotherapy effect on appendiceal cancer treated with CRS/HIPEC. C…
RT @LanaBijelicMD: Breaking new ground in appendiceal cancer research-congrats @KVotanopoulos and team! @acpmpresearch @vivirconPMP @Append…
RT @LanaBijelicMD: Breaking new ground in appendiceal cancer research-congrats @KVotanopoulos and team! @acpmpresearch @vivirconPMP @Append…
RT @LanaBijelicMD: Breaking new ground in appendiceal cancer research-congrats @KVotanopoulos and team! @acpmpresearch @vivirconPMP @Append…
RT @acpmpresearch: ACPMP is so proud to provide financial support for this important research that will improve care for our patients!
ACPMP is so proud to provide financial support for this important research that will improve care for our patients!
RT @LanaBijelicMD: Breaking new ground in appendiceal cancer research-congrats @KVotanopoulos and team! @acpmpresearch @vivirconPMP @Append…
RT @LanaBijelicMD: Breaking new ground in appendiceal cancer research-congrats @KVotanopoulos and team! @acpmpresearch @vivirconPMP @Append…
@VirajLavingia @oncologician @SirohiBhawna
Breaking new ground in appendiceal cancer research-congrats @KVotanopoulos and team! @acpmpresearch @vivirconPMP @AppendixPMP @PMPSurvivor @pmppalsnetwork
RT @KVotanopoulos: Our new pub in CCR is now early released online. Immunotherapy effect on appendiceal cancer treated with CRS/HIPEC. C…
RT @KVotanopoulos: Our new pub in CCR is now early released online. Immunotherapy effect on appendiceal cancer treated with CRS/HIPEC. C…
Our new pub in CCR is now early released online. Immunotherapy effect on appendiceal cancer treated with CRS/HIPEC. Can we possibly use organoid data to guide clinical trial enrollment in rare diseases? Supported by the ACPMP and NORD grant. https://t
Organoid Platform in Preclinical Investigation of Personalized Immunotherapy Efficacy in Appendiceal Cancer: Feasibility Study https://t.co/UhiWxvoM9M